Targeted Therapy for Metastatic Renal Cell Carcinoma

Targeted Therapy for Metastatic Renal Cell Carcinoma

In the past 10 years, recent development of targeted therapy in metastatic renal cell carcinoma (mRCC) has provided a new hope and significantly enhanced the prognosis of the disease. Three class of targeted therapy were developed, including multi-targeted tyrosine kinase inhibitors (TKI), the mamma...

Full description

Bibliographic Details
Main Authors:	Andika Afriansyah, Agus Rizal AH. Hamid, Chaidir A Mochtar, Rainy Umbas
Format:	Article
Language:	English
Published:	Interna Publishing 2017-02-01
Series:	Acta Medica Indonesiana
Subjects:	clear cell metastatic non-clear cell renal cell carcinoma sequential therapy targeted therapy
Online Access:	http://www.actamedindones.org/index.php/ijim/article/view/266

Similar Items

Rationale for Prostate-Specific-Membrane-Antigen-Targeted Radionuclide Theranostic Applied to Metastatic Clear Cell Renal Carcinoma
by: Anne Laure Giraudet, et al.
Published: (2023-07-01)

METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA: AN EVIDENCE BASED REVIEW OF CURRENT TREATMENT STRATEGIES
by: Alexander eSankin, et al.
Published: (2015-04-01)

Renal Cell Carcinoma with Testicular Metastases: A Case Report and Review of the Literature
by: Sho Yoshitake, et al.
Published: (2022-05-01)

Renal Cell Carcinoma with Cardiac Metastases: A Case Report and Review of the Literature
by: Ellen M. Cahill, et al.
Published: (2022-05-01)

Renal Cell Carcinoma with Cardiac Metastases: A Case Report and Review of the Literature
by: Ellen M. Cahill, et al.
Published: (2022-05-01)

Renal Cell Carcinoma with Testicular Metastases: A Case Report and Review of the Literature
by: Sho Yoshitake, et al.
Published: (2022-05-01)

Solitary metastatic clear cell carcinoma to the spleen
by: Mohamed A. Zayed, et al.
Published: (2011-10-01)

Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma
by: Ruiyang Xie, et al.
Published: (2023-12-01)

Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
by: Jung Kwon Kim, et al.
Published: (2019-07-01)

Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis
by: Shen J, et al.
Published: (2019-06-01)

A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy
by: Sung Han Kim, et al.
Published: (2022-11-01)

Current perspectives on systemic therapy for metastatic non-clear cell renal cell carcinoma
by: J. González, et al.
Published: (2020-12-01)

Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor
by: Haixiang Shen, et al.
Published: (2021-11-01)

RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis
by: Lin Yang, et al.
Published: (2018-02-01)

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
by: Cesar U. Monjaras-Avila, et al.
Published: (2023-04-01)

Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
by: Valentina Schiavoni, et al.
Published: (2023-06-01)

Selection of Optimal Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Predictive Model Based on SEER Database
by: Yishan Zhang, et al.
Published: (2022-01-01)

Genetics and Tumor Microenvironment of Renal Cell Carcinoma
by: Sari Khaleel, et al.
Published: (2022-11-01)

Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report
by: Caterina Marra, et al.
Published: (2023-01-01)

Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
by: Luigi Napolitano, et al.
Published: (2023-04-01)

Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis
by: Weimin Zhong, et al.
Published: (2021-06-01)

Management of metastatic renal cell carcinoma – mini review
by: Anubha Bharthuar, et al.
Published: (2015-05-01)

The renal clear cell carcinoma immune landscape
by: Omar A. Saad, et al.
Published: (2022-02-01)

Renal cell carcinoma in Nigeria: A systematic review
by: Akinfenwa Taoheed Atanda, et al.
Published: (2017-01-01)

Metastatic Immune-Related Genes for Affecting Prognosis and Immune Response in Renal Clear Cell Carcinoma
by: Si Sun, et al.
Published: (2022-01-01)

Renal cell carcinoma and xanthogranulomatous pyelonephritis: A diagnostic challenge
by: Mohammed Khalidur Rahman, et al.
Published: (2018-01-01)

Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC)
by: Jacek Rysz, et al.
Published: (2021-12-01)

Sequential Therapy in Metastatic Renal Cell Carcinoma
by: Bradford R Hirsch, et al.
Published: (2016-04-01)

Metastatic Tumors of the Oro-Facial Tissues: Clear Cell Renal Cell Carcinoma. A Clinico-Pathological and Immunohistochemical Study of Seven Cases
by: Saverio Capodiferro, et al.
Published: (2020-04-01)

Primary Clear Cell Renal Cell Carcinoma with Marked Intraluminal Mucin Secretion
by: Oğuzhan OKCU, et al.
Published: (2019-01-01)

Hyalinizing clear cell carcinoma of the base of tongue: A distinct and rare entity
by: Suresh Masilamani, et al.
Published: (2011-01-01)

Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors – Case report
by: Daniel Suso-Palau, et al.
Published: (2022-07-01)

Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
by: Pierangela Sepe, et al.
Published: (2021-07-01)

Sporadic renal cell carcinoma with widespread metastasis in young patient: A rare case report
by: Andini Kartikasari, et al.
Published: (2023-07-01)

Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management
by: Jean Courcier, et al.
Published: (2020-09-01)

Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-12-01)

Can Incomplete Metastasectomy Impact Renal Cell Carcinoma Outcomes? A Propensity Score Matching Analysis From a Prospective Multicenter Collaboration
by: Alice Dragomir, Charles Hesswani, Gautier Marcq, Alan I So, Christian Kollmannsberger, Naveen S. Basappa, Adrian Fairey, Anil Kapoor, Aly-Khan A. Lalani, Antonio Finelli, Lori A Wood, Daniel Y.C. Heng, Georg Bjarnason, Rodney H. Breau, Luke T. Lavallée, Denis Soulières, Darrel Drachenberg, Frédéric Pouliot, Simon Tanguay
Published: (2021-03-01)

Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy
by: Yan Song, et al.
Published: (2016-01-01)

Heart Metastases of Clear Cell Renal Cell Carcinoma
by: Katarzyna Romejko, et al.
Published: (2023-04-01)

Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy
by: Wenjie Yang, et al.
Published: (2023-05-01)